期刊文献+

基于核磁共振的甲状腺乳头状癌患者血浆的代谢组学研究 被引量:3

A plasma metabolomics study of papillary thyroid cancer with NMR
下载PDF
导出
摘要 目的通过核磁共振代谢组学方法进行甲状腺乳头状癌患者与健康对照者血浆代谢组研究,并探讨甲状腺乳头状癌组代谢组学上的变化及意义。方法收集健康对照组(n=29)和甲状腺乳头状癌组(n=31)血浆样品,进行核磁共振氢谱(1 H-NMR)检测。通过最小二乘判别分析(OPLS-DA)方法得到两组血浆的差异性代谢物,并探讨相关生化过程的改变。结果两组血浆代谢物有明显的差异,与健康对照组相比,甲状腺乳头状癌组血浆中的极低密度脂蛋白、异亮氨酸、亮氨酸、缬氨酸、低密度脂蛋白、乳酸、丙氨酸、糖蛋白、谷氨酰胺、肉碱、α-酮戊二酸、肌酸、甘氨酸、不饱和脂类、酪氨酸、甲基组氨酸、苯丙氨酸的含量降低,丙酮酸、柠檬酸、肌酸酐、胆碱、鲨肌醇、β-葡萄糖、肌醇、α-葡萄糖和甲酸的含量增高,差异有统计学意义(P<0.05)。结论根据血浆代谢物的差异可以分辨健康对照组与甲状腺乳头状癌组血浆中的差异性代谢物。这种基于核磁共振氢谱技术的代谢组学方法可为甲状腺乳头状癌的诊断提供可靠代谢依据。 Objective Nuclear magnetic resonance (NMR)was used to study of papillary thyroid carcinoma group′s blood plasma and health group′s blood plasma metabolomics and their significance.Methods Blood plasma of healthy people group (n=29)and patients group with papillary thyroid carcinoma (n=3 1 )were collected and were analyzed by the method of ^1 H-NMR .Different metabolites of two sets of plasma were obtained by using orthogonal proj ections to latent structures discriminant analysis (OPLS-DA), and the related changes in biochemical processes were investigated.Results There were significant differences between the two groups in plasma metabolites,which were the concentration level of VLDL,isoleucine,leucine,valine,LDL,lactic acid,alanine,glycoproteins,glutamine,carnitine,α-ketoglutaric acid, creatine,glycine,unsaturated lipids,tyrosine,methyl histidine,phenylalanine were reduced,while pyruvic acid,citric acid,creatinine,choline,shark inositol,β-glucose,inositol,α-glucose and formic acid level were increased in plasma of patients with papillary thyroid carcinoma,there were significant differences (P〈0.05)compared with the healthy group.Conclusion Based on differences in plasma metabolites we can distinguish differences in plasma metabolites of healthy people and patients with papillary thyroid carcinoma .such metabolomics technology method based ^1 H-NMR provide a reliable metabolism basis for diagnosis of papillary thyroid carcinomale.
出处 《新疆医科大学学报》 CAS 2014年第9期1130-1134,共5页 Journal of Xinjiang Medical University
基金 国家自然科学基金(30860275)
关键词 甲状腺乳头状癌 代谢组学 核磁共振 papillary thyroid carcinoma metabolomics NMR
  • 相关文献

参考文献20

  • 1Greenlee RT, Hill-Harmon MB, Murray T, et al. Cancer sta- tistics, 2001[J]. CA Cancer Clin, 2001, 51(1):15-36.
  • 2刘跃武,高维生,唐伟松.应更好地规范甲状腺癌的初次手术[J].中国普外基础与临床杂志,2006,13(3):254-255. 被引量:14
  • 3Hegedus L. Clinical practice; the thyroid nodule[J]. N Engi Med, 2004, 35(1):1764-1771.
  • 4王征新,杨波.结节性甲状腺肿合并甲状腺癌20例临床探析[J].基层医学论坛,2013,17(17):2224-2225. 被引量:3
  • 5Moses W, Weng J, Sansano I, et al. Molecular testing for so- matic mutations improves the accuracy of thyroid fine needle aspiration biopsy[J].World J Surg, 2010, 34(11):2589-2594.
  • 6Kunle O,Robert M, Christine B, et al.Detection of epithelial o- varian cancer using H-NMR based metabonomics[J]. Int J Cancer, 2005, 113(5) :782-788.
  • 7Thysell E,Pohjianen E, Lindberg J,et al.Reliable profile detec- tion in comparative metabolomics[J]. OMICS, 2007, 11 (2) 209-224.
  • 8Duarte IF, Goodfellow BJ, Barros A, et al. Metabolic eharac terization of plasma injuveniles with glycogen storage disease type la (GSDla)by high resolution 1H-NMR spectroscopy[J].NMR Biomed, 2007, 20(1):401-412.
  • 9Hu C, van der Heiiden R, Wang M, et al. Analytical strategies in lipidomics and applications in disease biomarker diseovery[J]. Chromatography B, 2009, 877(26) :2836-2846.
  • 10Yuan KL, Kong HW, Guan YF, et al. GC MS Based Plasma Metabolic Profiling of Type 2 Diabetes Mellitus[J]. Chroma tographv B, 2007, 850(10) :236-240.

二级参考文献44

共引文献31

同被引文献32

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部